Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition

Abstract Background 177Lu-PSMA therapy has been successfully used to prolong the survival of patients with metastatic castration-resistant prostate cancer. Patient-specific dosimetry based on serial quantitative SPECT/CT imaging can support the understanding of dose–effect relationships. However, mu...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Sandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, Gabriel T. Sheikh, Grigory Liubchenko, Mikhail Rumiantcev, Lena M. Unterrainer, Vera Wenter, Peter Bartenstein, Sibylle I. Ziegler, Harun Ilhan, Leonie Beyer, Guido Böning, Astrid Delker
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	SpringerOpen 2023-02-01
Ráidu:	EJNMMI Physics
Fáttát:	SPECT PSMA 177Lu Prostate cancer Dosimetry
Liŋkkat:	https://doi.org/10.1186/s40658-023-00529-8
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!